We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

121 hedge funds and large institutions have $528M invested in Rigel Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 52 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

319% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $341K

148% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 21

90% more capital invested

Capital invested by funds: $278M → $528M (+$250M)

87% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 15

12% more funds holding

Funds holding: 108 → 121 (+13)

0.51% more ownership

Funds ownership: 8.77% → 9.29% (+0.51%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
121
Holders Change
+13
Holders Change %
+12.04%
% of All Funds
2.74%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
28
Increased
52
Reduced
21
Closed
15
Calls
$1.43M
Puts
$341K
Net Calls
+$1.09M
Net Calls Change
+$793K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$19.9M
2
Citadel Advisors
Citadel Advisors
Florida
+$14.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.6M
4
BC
Boxer Capital
California
+$12M
5
Millennium Management
Millennium Management
New York
+$10.9M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$4.63M
2
SCM
Sio Capital Management
New York
-$2.58M
3
RPAM
Rhenman & Partners Asset Management
Sweden
-$1.59M
4
Wells Fargo
Wells Fargo
California
-$1.24M
5
GTC
Ghost Tree Capital
New York
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
DAFNA Capital Management
California
$3.82M +$2.06M +54,000 +122%
SCM
27
Sio Capital Management
New York
$3.43M -$2.58M -67,825 -43%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$3.42M – – –
State of New Jersey Common Pension Fund D
29
State of New Jersey Common Pension Fund D
New Jersey
$3.3M – – –
GTC
30
Ghost Tree Capital
New York
$3.2M -$1.05M -27,500 -25%
Macquarie Group
31
Macquarie Group
Australia
$3.04M +$190K +5,000 +7%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.9M +$745K +19,579 +35%
Renaissance Technologies
33
Renaissance Technologies
New York
$2.51M +$1.58M +41,609 +180%
PVI
34
Pura Vida Investments
New York
$2.35M +$2.3M +60,456 New
AllianceBernstein
35
AllianceBernstein
Tennessee
$1.95M +$31.6K +830 +2%
Goldman Sachs
36
Goldman Sachs
New York
$1.82M +$1.07M +28,123 +150%
Barclays
37
Barclays
United Kingdom
$1.65M +$981K +25,769 +153%
CM
38
Crestline Management
Texas
$1.49M +$210K +5,516 +17%
USAA
39
United Services Automobile Association
Texas
$1.38M +$96.3K +2,529 +8%
TCIM
40
TIAA CREF Investment Management
New York
$1.29M +$102K +2,689 +9%
BCPEM
41
Bain Capital Public Equity Management
Massachusetts
$1.21M +$1.18M +31,096 New
Morgan Stanley
42
Morgan Stanley
New York
$1.2M +$496K +13,045 +73%
WMSA
43
Weiss Multi-Strategy Advisers
New York
$1.16M +$883K +23,200 +341%
Charles Schwab
44
Charles Schwab
California
$1.16M +$119K +3,120 +12%
TA
45
Teachers Advisors
New York
$1.03M +$146K +3,826 +17%
EGI
46
EAM Global Investors
California
$978K +$959K +25,197 New
TI
47
Telemetry Investments
New York
$931K +$152K +3,990 +20%
Two Sigma Investments
48
Two Sigma Investments
New York
$919K +$847K +22,242 +1,550%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$905K +$127K +3,350 +17%
Swiss National Bank
50
Swiss National Bank
Switzerland
$891K +$874K +22,960 New
1
2
3 4 5

RIGL Hedge Fund Activity: Q4 2017 in Review

121 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2017, worth a combined $528M — up 90% from $278M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RIGL positions and 15 closed out — a net gain of 13 holders — while 52 added to existing stakes and 21 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $19.9M. The largest seller was Great Point Partners, cutting an estimated $4.63M.

  • 121 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2017, up from 108 in Q3 2017.
  • Funds reported $528M of Rigel Pharmaceuticals stock for Q4 2017, up 90% quarter-over-quarter.
  • 28 funds opened new Rigel Pharmaceuticals positions in Q4 2017 and 15 closed out, a net change of +13 holders.
  • The largest Rigel Pharmaceuticals buyer in Q4 2017 was Wellington Management Group, an estimated $19.9M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2017 was Great Point Partners, an estimated $4.63M sold.

Based on aggregated 13F filings for Q4 2017.